ASP-3700
- Generic Name
- ASP-3700
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP3700 in Healthy Subjects
Phase 1
Withdrawn
- Conditions
- Pharmacokinetics of ASP3700Healthy Volunteers
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-11-07
- Last Posted Date
- 2015-01-12
- Lead Sponsor
- Astellas Pharma Europe B.V.
- Registration Number
- NCT02285465
A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP3700 in Healthy Male Subjects
Phase 1
Completed
- Conditions
- Healthy VolunteersPharmacokinetics of ASP3700
- Interventions
- First Posted Date
- 2014-06-04
- Last Posted Date
- 2014-10-30
- Lead Sponsor
- Astellas Pharma Europe B.V.
- Target Recruit Count
- 44
- Registration Number
- NCT02155504
- Locations
- 🇬🇧
Parexel Early Phase Clinical Unit, Harrow, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath